The purpose of this study was to determine if caffeine augments the slow-pressor response to chronic low-dose infusions of angiotensin II (AII) or the rapid-pressor response to acute infusions of AII. AII was infused (125 ng/min i.p.) for 12 d via mini-osmotic pumps in four groups of rats: group I, intact rats not treated with caffeine (n = 9); group II, intact rats treated with caffeine (0.1% in drinking water, n = 9); group III, rats previously sympathectomized with 6-hydroxydopamine, but not treated with caffeine (n = 10); and group IV, rats previously sympathectomized with 6-hydroxydopamine and treated with caffeine (n = 10). Chronic lowdose AII infusions slowly elevated systolic blood pressure in all groups. Caffeine greatly augmented this slow-pressor response to AII in intact animals; however, caffeine failed to enhance AII-induced hypertension in sympathectomized rats. Caffeine pretreatment did not enhance the rapid-pressor response to acute intravenous infusions of AII. We conclude that caffeine augmented the slow-pressor effect of chronic low-dose infusions of AII via a mechanism that involved the sympathetic nervous system.
Introduction
Recently, we discovered that chronic administration of caffeine to rats with 2-kidney, 1-clip Goldblatt hypertension accelerates the development of hypertension and increases the maximal level of blood pressure achieved (1) . We are currently investigating the mechanism by which caffeine exerts this remarkable effect. It appears that caffeine must potentiate 2-kidney, 1-clip hypertension by somehow interacting with the renin-angiotensin system. This conclusion is supported by the facts that caffeine does not exacerbate hypertension in animal models in which plasma renin levels remain low or normal, and that converting enzyme inhibition prevents caffeine from potentiating hypertension in rats with unilateral renal artery stenosis (1) . Further, caffeine increases plasma renin activity by sevenfold in 2-kidney, 1-clip rats (1) , which suggests that caffeine exacerbates 2-kidney, 1-clip hypertension, at least in part, by enhancing the reninrelease response to renal ischemia.
Although caffeine-induced enhancement of the renin response to renal ischemia most likely contributes to caffeine-induced potentiation of renovascular hypertension, other mechPlease address all correspondence and reprint requests to Dr. E. K. Jackson, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Receivedfor publication 16 December 1986. anisms may also participate. Specifically, it is possible that caffeine also directly potentiates the pressor effect of angiotensin II (All).' The purpose ofthe study presented here was to examine this hypothesis. Since the mechanism by which All increases arterial blood pressure may depend on the duration and dose of infusion, we studied the effects of caffeine on both the slowpressor response to chronic low-dose infusions of All and the rapid-pressor response to acute intravenous infusions of All.
Methods
Male Sprague Dawley rats were obtained from Sasco (Omaha, NE) and acclimated to the Vanderbilt animal care facility for 1 wk. Animals were given a diet of Wayne Lab Blox (Allied Mills, Inc., Chicago, IL) that contained 170 meq Na+/kg and 246 meq K+/kg. Water was allowed ad lib., and animals were maintained on a constant 12-h light/dark cycle (lights on 6:00 a.m. to 6:00 p.m.). During the second week, rats were trained on three separate sessions for systolic blood pressure (SBP) measurement. SBP was measured by using the photoelectric tail cuffsystem (model 20-NW cuffpump, model 59 pulse amplifier, and model 65-24 manual scanner, IITC, Inc., Woodland Hills, CA) as previously described (2) . This system permits measurement of SBP at an ambient temperature of 270C. The SBP for any particular day was taken as the average ofthree separate determinations made on that day.
After animals were trained to the photoelectric tail cuff system, baseline SBPs were determined, and the next day Alzet mini-osmotic pumps (model 2002; Alza Corp., Palo Alto, CA) were implanted into the animals' peritoneal cavities. Each animal received a mini-osmotic pump implant that provided an All-infusion rate of 125 ng/min. SBP was measured 3, 6, 9, and 12 d after implantation of the mini-osmotic pump.
Four groups of rats were studied. Group I rats (n = 9) received no treatment other than the All infusion and served as a control for the group II rats. Group II animals (n = 9) were given drinking water that contained 0.1% caffeine. Treatment with caffeine began 7 d before initiating the All infusion. It was previously shown that this dose ofcaffeine does not alter arterial blood pressure in normal rats (1, 3) , but does potentiate renovascular hypertension and provides plasma caffeine levels of -10 0sg/ml (1) . Chronic administration ofdrinking water containing 0.1% caffeine does not alter water or food intake, urinary sodium or potassium excretion, or urine volume (1) . Group III rats (n = 10) were not given caffeine, but were pretreated with 6-hydroxydopamine that began 2 wk before initiating the AII infusion. 6-Hydroxydopamine was administered according to the following schedule: 100 mg/kg i.p. (dissolved in 0.25% ascorbic acid in 0.9% saline) administered 14, 13, 7, 6, and 3 d before implantation of the mini-osmotic pumps. Group III rats served as controls forgroup IV rats. Group IV rats (n = 10) were pretreated with caffeine and 6-hydroxydopamine as described above and also received an All infusion.
On the 13th day after implantation of the mini-osmotic pump, five rats from groups I and II and five from groups III and IV were selected at random and prepared for in situ perfusion oftheir mesenteric vascular beds as described previously (4 ulation and exogenous norepinephrine were elicited and recorded as previously described (4) . Two more groups of rats were pretreated for 1 wk with either normal drinking water (n = 7) or drinking water containing 0.1% caffeine (n = 20). After pretreatment, each rat was anesthetized with pentobarbital, and polyethylene catheters (PE-50; Clay Adams Div., Parsippany, NJ) were inserted into the left jugular vein and carotid artery. The catheters were tunneled subcutaneously, exteriorized to the nape of the neck, and protected with a jacket-tether-swivel system (Alice King Chatham, Medical Arts, Los Angeles, CA). The animals ate and drank freely once they regained consciousness. 24 h after surgery, the intravenous catheter was connected to an infusion pump (model 931; Harvard Apparatus Co., Inc., South Natick, MA), and the intraarterial catheter was connected to a pressure transducer (model 1280; Hewlett-Packard Co., Palo Alto, CA). Mean arterial blood pressure was continuously recorded on a physiological recorder (model 7758A; Hewlett-Packard Co.).
30 min before the experiment, some of the rats that had been pretreated with caffeine were given either a 2-mg (n = 7) or 15-mg (n = 6) intravenous bolus of caffeine, whereas intravenous caffeine was not given to any ofthe other rats. This allowed us to examine the effects ofcaffeine on the rapid-pressor response to All over a wide range ofplasma caffeine levels.
A cumulative dose-response curve to intravenous infusions of All 
Results
As shown in Fig. 1 , chronic low-dose infusions of All caused a gradual increase in SBP in non-caffeine-treated rats. In rats treated with caffeine, All caused a much greater rise in SBP, which indicates that caffeine enhanced the slow-pressor effect of All. Fig. 2 summarizes the effect of chronic low-dose infusions of All on SBP in sympathectomized rats. Baseline SBP was somewhat lower (P < 0.001) in sympathectomized rats (95±3 and 96±2 mmHg in non-caffeine-treated and caffeine-treated sympathectomized rats, respectively) than in those with an intact sympathetic nervous system (116±3 and 119±4 mmHg in noncaffeine-treated and caffeine-treated, intact rats, respectively).
Nonetheless, All caused a gradual increase in SBP in sympathectomized animals; however, in rats pretreated with 6-hydroxydopamine, caffeine no longer augmented the slow-pressor response to All. Fig. 3 shows the vascular responses to sympathetic nerve stimulation and exogenous norepinephrine in intact rats and those sympathectomized with 6-hydroxydopamine. Vascular responses to sympathetic nerve stimulation were greatly diminished in rats pretreated with 6-hydroxydopamine as compared with intact animals, which indicates a high degree ofsympathectomy. In contrast, vascular responses to exogenous norepinephrine were enhanced in 6-hydroxydopamine-pretreated animals versus intact animals, which indicates denervation-induced postjunctional supersensitivity. Time (Days) Figure 1 . Effect of caffeine on the slow-pressor response to chronic low-dose infusions (125 ng/min i.p.) of All in intact rats. (o) 0.1% caffeine in drinking water (n = 9); (-) no caffeine in drinking water (n = 9). * and ** indicate P < 0.05 and P < 0.01, respectively, compared with the corresponding time in non-caffeine-treated group (unpaired t test). The time-pressure relationship in the caffeine-treated group was significantly (P < 0.001) elevated compared with that in the non-caffeine-treated group (repeated measures two-factor analysis of variance).
The rapid-pressor responses to intravenous infusions of AII were similar in all rats pretreated for 1 wk with caffeine, regardless of whether or not more caffeine (i.e., 2 or 15 mg) had been administered 30 min before the experiment. Therefore, the data from these 20 rats were combined. As shown in Fig. 4 , caffeine pretreatment did not affect the acute rapid-pressor response to any dose of AI.
Discussion
The purpose ofthis study was to test the hypothesis that caffeine can enhance the pressor response to All. Accordingly, a low dose of All was infused chronically or several doses of All were infused acutely into control and caffeine-treated animals. Chronic low-dose infusions of All caused a much greater rise in SBP of caffeine-pretreated animals as compared with noncaffeine-treated animals. In contrast, caffeine did not potentiate the rapid-pressor response to acute infusions of All. These findings demonstrate that caffeine specifically enhanced the slowpressor effect of All without potentiating the rapid-pressor response to All. This result posed a question of how caffeine potentiates the slow-pressor effect of All. To address this question, the study was repeated in animals in which peripheral sympathetic nerve terminals had been destroyed by previous treatment with 6-hydroxydopamine. In sympathectomized animals, All still exerted a slow-pressor effect; however, in this situation caffeine failed to potentiate the slow-pressor response to All. This finding strongly suggests that caffeine enhanced the slow-pressor effect of All by somehow enhancing the interaction of All with the sympathetic nervous system.
The site of this putative caffeine-All-sympathetic interaction is unknown. All interacts with the sympathetic nervous system both centrally and peripherally. Blood-borne All gains access to periventricular structures that lack a blood-brain barrier, activates specific All receptors, and causes an increase in sympathetic tone (5) . It is possible that caffeine in some way enhances the effects of All on centrally mediated sympathetic tone, either directly by influencing All sensitive neurons or indirectly by influencing other neurons that modulate the effect ofthose neurons directly activated by All. In addition, All also enhances sympathetic neurotransmission at the level of the peripheral noradrenergic varicosity. At this site, All facilitates norepinephrine release, decreases norepinephrine reuptake, and potentiates the postjunctional effects of norepinephrine (6) . If caffeine enhances the action of All at any of these sites, this could also explain our observations. These two mechanisms are not mutually exclusive, and a caffeine-All interaction occurring simultaneously both centrally and peripherally is logically possible. It is noteworthy that caffeine enhances the chronic slowpressor response, but not the acute rapid-pressor response, to All. The slow-pressor response to All is most likely due to a rightward shift in the renal pressure-natriuresis relationship (7) . Therefore, the most plausible interpretation ofour results is that caffeine, by enhancing the effects ofAll on the sympathetic nervous system, increased the effects of All on the renal pressurenatriuresis mechanism.
Predictably, the baseline arterial blood pressure was lower in those animals treated with 6-hydroxydopamine as compared with normal animals (compare baseline SBPs in Figs. 1 and 2 ). It is possible that this shift in baseline, and not the sympathectomy per se, prevented caffeine from enhancing the slow-pressor response to All. However, this seems unlikely since the SBPs 12 d into the All infusion were similar in control and 6-hydroxydopamine-treated animals, yet caffeine increased the SBP in the control animals, but not in the sympathectomized animals.
As explained in the introduction, we had previously observed that chronic caffeine treatment exacerbated the development of 2-kidney, 1-clip hypertension (1) . In that study, we also found that caffeine increases plasma renin activity sevenfold and that converting enzyme inhibition prevents caffeine from augmenting 2-kidney, 1-clip hypertension. We interpreted these results to mean that caffeine exacerbates renovascular hypertension in part by augmenting the renin-release response to renal ischemia. However, the possibility that caffeine may have additional mechanisms of action in renovascular hypertension was acknowledged. Given the results of this study, it now seems clear that caffeine exerted a dual effect in renovascular hypertension. Evidently, caffeine potentiated renovascular hypertension by affecting both ends of the renin-angiotensin axis. That is to say, caffeine not only augmented the renin response to renal ischemia, but also increased the slow-pressor effect ofAll. This dual action of caffeine would explain the remarkable efficacy of caffeine to exacerbate 2-kidney, 1-clip hypertension.
The interaction of caffeine with the sympathetic nervous system is complex. In this study, we found that caffeine augmented the slow-pressor effect of All by enhancing All interactions with the sympathetic nervous system. In contrast, in an elegant series of studies von Borstel et al. (8, 9) found that adenosine potentiates the effects of nicotine on sympathetic ganglia and that caffeine, by blocking adenosine receptors, inhibits the sympathomimetic effects of nicotine. The diametrically opposite effect of caffeine on All versus nicotine-induced hypertension probably reflects the fact that adenosine inhibits the sympathetic nervous system at some sites, such as the peripheral noradrenergic neuroeffector junction (10) or the central nervous system (1 1), while stimulating the sympathetic nervous system at other sites, such as the sympathetic ganglia (8, 9) . Therefore, whether caffeine augments or inhibits the sympathomimetic effects of a particular agent would depend on the specific site of action of that substance within the sympathetic nervous system.
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In summary, our results demonstrate that caffeine augmented the slow-pressor response, but not the rapid-pressor response, to All by enhancing the import of All interactions with the sympathetic nervous system.
